Human milk oligosaccharides in milk of mothers with term and preterm delivery at different lactation stage

Carbohydr Polym. 2023 Dec 1:321:121263. doi: 10.1016/j.carbpol.2023.121263. Epub 2023 Aug 6.

Abstract

Human milk oligosaccharides (HMOs) are structurally diverse unconjugated glycans, and play crucial roles in protecting infants from infections. Preterm birth is one of the leading causes of neonatal mortality, and preterm infants are particularly vulnerable and are in need of improved outcomes from breast-feeding due to the presence of bioactive HMOs. However, studies on specific difference in HMOs as a function of gestation time have been very limited. We established an approach to extract and analyze HMOs based on 96-well plate extraction and mass spectrometry, and determined maternal phenotypes through distinctive fragments in product-ion spectra. We enrolled 85 women delivering at different gestation times (25-41 weeks), and observed different HMOs correlating with gestation time based on 233 samples from the 85 donors. With the increase of postpartum age, we observed a regular changing trajectory of HMOs in composition and relative abundance, and found significant differences in HMOs secreted at different postpartum times. Preterm delivery induced more variations between participants with different phenotypes compared with term delivery, and more HMOs varied with postpartum age in the population of secretors. The sialylation level in mature milk decreased for women delivering preterm while such decrease was not observed for women delivering on term.

Keywords: Distinctive oligosaccharides; Duration of gestation; Human milk oligosaccharides (HMOs); Phenotype; Preterm delivery.

MeSH terms

  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Lactation
  • Milk, Human*
  • Mothers
  • Oligosaccharides
  • Premature Birth*

Substances

  • Oligosaccharides